BCL6 and liver cancer: To demonstrate the necessity of Bcl6 in liver cancer progression, we constructed two BCL6 knockout cell lines using CRISPR/Cas9 technology in H22, and the knockout efficiency of BCL6 was confirmed using quantitative PCR (qPCR) as shown in Fig. 2a as well as genomic PCR results (Fig. S2).